RxDoctor Payments DataLook up a doctor →

Amy Malmedahl, NP

Gerontology · Cincinnati, OHNPI 1780298703

Payments from drug & device makers

$10,735in general payments, 2019–2025

Across 387 payments — averaging $27.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$4K
  • Boston Scientific$2K
  • Novartis$871
  • Boehringer Ingelheim$802
  • Johnson & Johnson$546
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$428
  • plus $3K from 37 others

What the payments were for

  • Travel & lodging$2,47023%
  • Food & beverage$8,26577%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,735 in reported general payments places this provider in the 95th percentile of 361 gerontology providers in Ohio.

See all gerontology providers in Ohio

Medicare billing

Part B allowed, 2024
$63,730
Medicare patients
398
Services billed
1,048

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban688$780,109
XareltoRivaroxaban302$366,670
Dofetilide134$25,832
Metoprolol Succinate487$7,363
Diltiazem 24hr Er (Cd)Diltiazem Hcl223$6,637
Propafenone Hcl ErPropafenone Hcl13$5,287
Flecainide Acetate102$5,039
Amiodarone Hcl216$3,317
Mexiletine Hcl19$3,215
Propafenone Hcl38$2,104
Propranolol Hcl ErPropranolol Hcl20$1,048
Warfarin Sodium106$875
Diltiazem 12hr ErDiltiazem Hcl13$873
Digoxin58$836
Diltiazem 24hr ErDiltiazem Hcl14$768

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$84$780,109688 claims
Johnson & JohnsonXarelto$546$366,670302 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 361 gerontology providers in Ohio.

Other gerontology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →